Skip to main content

Advertisement

SpringerLink
Log in

miR-19a and miR-19b Overexpression in Gliomas

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Astrocytic gliomas are the most common type of human primary brain tumors with poor prognosis. MicroRNAs(miRs) are frequently deregulated in gliomas and play an oncogenic or tumor suppressor role. In our previous study we found that miR-19a and miR-19b were up-regulated in malignant glioma cell lines by microRNA array. For further validation of this finding, the expression of miR-19a and miR-19b was detected by qRT-PCR and in situ hybridization(ISH) in 8 malignant glioma cell lines, 43 freshly resected glioma samples and 75 archival paraffin embedded glioma specimens with different grades of malignancy in the present study. The results demonstrate that miR-19a and miR-19b are overexpressed in glioma cell lines and astrocytic glioma tissues, and their expression level is positively correlated with tumor grades. Additionally, the tumor suppressor gene PTEN is identified as the target of miR-19a and miR-19b by Luciferase assay. It is speculated that miR-19a and miR-19b may have an oncogenic role in gliomagenesis at least partially via the negative regulation of PTEN and the molecular mechanism of gliomagenesis in which miR 19a and miR-19b involved should be investigated further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97–117

    Article  PubMed  CAS  Google Scholar 

  2. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  PubMed  CAS  Google Scholar 

  3. Chen L, Li C, Zhang R et al (2011) miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Cancer Lett 309(1):62–70

    Article  PubMed  CAS  Google Scholar 

  4. Takakura S, Mitsutake N, Nakashima M et al (2008) Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 99(6):1147–1154

    Article  PubMed  CAS  Google Scholar 

  5. Ruan JS, Chen HZ, Kurgan L et al (2008) HuMiTar: a sequence-based method for prediction of human microRNA targets. Algorithm Mol Biol 3:16

    Article  Google Scholar 

  6. You Y, Pu P, Huang Q et al (2006) Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo. Int J Oncol 28:1225–1232

    PubMed  CAS  Google Scholar 

  7. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033

    Article  PubMed  CAS  Google Scholar 

  8. Zhang Y, Dutta A, Abounader R (2012) The role of microRNAs in glioma initiation and progression. Front Biosci 17:700–712

    Article  CAS  Google Scholar 

  9. Ota A, Tagawa H, Karnan S et al (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64:3087–3095

    Article  PubMed  CAS  Google Scholar 

  10. Hayashita Y, Osada H, Tatematsu Y et al (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65:9628–9632

    Article  PubMed  CAS  Google Scholar 

  11. Tagawa H, Karube K, Tsuzuki S et al (2007) Synergistic action of the microRNA-17 poly-cistron and Myc in aggressive cancer development. Cancer Sci 98:1482–1490

    Article  PubMed  CAS  Google Scholar 

  12. Liang Z, Li Y, Huang K et al (2011) Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 28(12):3091–3100

    Article  PubMed  CAS  Google Scholar 

  13. Ye H, Liu X, Lv M et al (2012) MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia. Nucleic Acids Res 40(12):5201–5214

    Article  PubMed  CAS  Google Scholar 

  14. Baraniskin A, Kuhnhenn J, Schlegel U et al (2011) Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 117(11):3140–3146

    Article  PubMed  CAS  Google Scholar 

  15. Conkrite K, Sundby M, Mukai S et al (2011) miR-17-92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 25(16):1734–1745

    Article  PubMed  CAS  Google Scholar 

  16. Zhang X, Yu H, Lou JR et al (2011) MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 286(2):1429–1435

    Article  PubMed  CAS  Google Scholar 

  17. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T et al (2010) Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12(4):372–379

    Article  PubMed  CAS  Google Scholar 

  18. Ping M, Han Y-C, Bete D et al (2009) Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23(24):2806–2811

    Article  Google Scholar 

  19. Grillari J, Hackl M, Grillari-Voglauer R (2010) miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 11(4):501–506

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China (Grant No:81101915, Grant No: 30872985), Tianjin Health Service Science and Technique Foundation(Grant No: 2011KZ109)

Conflict of Interest

The authors have not conflict of interest.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Tianjin Neurological Institute, Laboratory of Neuro-Oncology, Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin Key Laboratory of Injuries, Variations and Regeneration of Nervous System, Tianjin Medical University General Hospital, 152 An-Shan Road, Tianjin, 300052, People’s Republic of China

    Zhifan Jia, Kun Wang, Anling Zhang, Guangxiu Wang, Chunsheng Kang, Lei Han & Peiyu Pu

Authors
  1. Zhifan Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anling Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guangxiu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chunsheng Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peiyu Pu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peiyu Pu.

Additional information

Zhifan Jia and Wang Kun contribute equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, Z., Wang, K., Zhang, A. et al. miR-19a and miR-19b Overexpression in Gliomas. Pathol. Oncol. Res. 19, 847–853 (2013). https://doi.org/10.1007/s12253-013-9653-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9653-x

Keywords

Search

Navigation